文献速递神经创伤神经重症

早期GFAP和UCH-L1即时检测生物标志物对多发伤合并失血性休克患者创伤性脑损伤及进展的预测

Early GFAP and UCH-L1 point-of-care biomarker measurements for the prediction of traumatic brain injury and progression in patients with polytrauma and hemorrhagic shock.
PubMed 文献 · J Neurosurg · 2024-05-10

本研究对一项前瞻性观察性队列研究的系列血样进行二次分析,用i-STAT Alinity即时检测平台测定多发伤合并失血性休克患者血浆GFAP和UCH-L1,以分类树递归划分确定预测TBI诊断、Rotterdam CT评分和6个月GOSE的界值。结果显示GFAP和UCH-L1在所有时间点均与TBI存在相关;入院GFAP>286 pg/ml预测TBI的AUC为0.77,入院GFAP界值3094 pg/ml对初始和第二次CT的Rotterdam评分升高及两次CT间TBI进展最具预测性;UCH-L1未发现与Rotterdam CT评分或TBI进展有显著关联。

要点

  • 入院GFAP>286 pg/ml预测CT诊断TBI的AUC为0.77。
  • 入院GFAP界值3094 pg/ml对Rotterdam评分升高及TBI进展最具预测性。
  • UCH-L1未发现与Rotterdam CT评分或TBI进展有显著关联。

核心结论

  • 即时检测设备早期测定GFAP和UCH-L1与多发伤合并休克患者CT诊断的TBI显著相关。
  • 早期GFAP升高与更差的头部CT Rotterdam评分、TBI进展和更差的GOSE评分相关,且这些关联独立于其他损伤特征、休克严重程度和早期复苏特征。

研究设计与样本

  • 对一项聚焦于比较早期全血与成分复苏的前瞻性观察性队列研究的系列血样进行二次分析。
  • 采用方便样本,样本在三个时间点采集,并通过CT影像记录有无TBI。
  • 使用i-STAT Alinity即时检测平台测定血浆GFAP和UCH-L1。
  • 采用分类树递归划分确定各生物标志物预测TBI诊断、Rotterdam CT评分和6个月GOSE评分的界值。

主要发现

  • 生物标志物比较显示GFAP和UCH-L1在所有时间点均与TBI存在相关。
  • 入院时采集样本的GFAP>286 pg/ml预测TBI的AUC为0.77。
  • 入院GFAP界值3094 pg/ml对初始和第二次CT的Rotterdam评分升高及两次CT间TBI进展最具预测性。
  • UCH-L1未发现与Rotterdam CT评分或TBI进展有显著关联。
  • UCH-L1的预测能力受即时检测平台允许范围的限制。

关键数值与推荐

  • 入院GFAP>286 pg/ml预测TBI的AUC为0.77。
  • 入院GFAP界值3094 pg/ml对初始和第二次CT的Rotterdam评分升高及两次CT间TBI进展最具预测性。
  • UCH-L1未发现与Rotterdam CT评分或TBI进展有显著关联。

局限性

  • UCH-L1的预测能力受即时检测平台允许范围的限制。
  • 采用方便样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Traumatic brain injury (TBI) and hemorrhage are responsible for the largest proportion of all trauma-related deaths. In polytrauma patients at risk of hemorrhage and TBI, the diagnosis, prognosis, and management of TBI remain poorly characterized. The authors sought to characterize the predictive capabilities of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) measurements in patients with hemorrhagic shock with and without concomitant TBI. METHODS: The authors performed a secondary analysis on serial blood samples derived from a prospective observational cohort study that focused on comparing early whole-blood and component resuscitation. A convenience sample of patients was used in which samples were collected at three time points and the presence of TBI or no TBI via CT imaging was documented. GFAP and UCH-L1 measurements were performed on plasma samples using the i-STAT Alinity point-of-care platform. Using classification tree recursive partitioning, the authors determined the measurement cut points for each biomarker to maximize the abilities for predicting the diagnosis of TBI, Rotterdam CT imaging scores, and 6-month Glasgow Outcome Scale-Extended (GOSE) scores. RESULTS: Biomarker comparisons demonstrated that GFAP and UCH-L1 measurements were associated with the presence of TBI at all time points. Classification tree analyses demonstrated that a GFAP level > 286 pg/ml for the sample taken upon the patient's arrival had an area under the receiver operating characteristic curve of 0.77 for predicting the presence of TBI. The classification tree results demonstrated that a cut point of 3094 pg/ml for the arrival GFAP measurement was the most predictive for an elevated Rotterdam score on the initial and second CT scans and for TBI progression between scans. No significant associations between any of the most predictive cut points for UCH-L1 and Rotterdam CT scores or TBI progression were found. The predictive capabilities of UCH-L1 were limited by the range allowed by the point-of-care platform. Arrival GFAP cut points remained strong independent predictors after controlling for all potential polytrauma confounders, including injury characteristics, shock severity, and resuscitation. CONCLUSIONS: Early measurements of GFAP and UCH-L1 on a point-of-care device are significantly associated with CT-diagnosed TBI in patients with polytrauma and shock. Early elevated GFAP measurements are associated with worse head CT scan Rotterdam scores, TBI progression, and worse GOSE scores, and these associations are independent of other injury attributes, shock severity, and early resuscitation characteristics.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sperry JL, Luther JF, Okonkwo DO, et al. Early GFAP and UCH-L1 point-of-care biomarker measurements for the prediction of traumatic brain injury and progression in patients with polytrauma and hemorrhagic shock. J Neurosurg. 2024. PMID: 39076152. doi:10.3171/2024.1.JNS232569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。